141 related articles for article (PubMed ID: 12021629)
1. Interpatient and intrapatient variability in phenytoin protein binding.
Banh HL; Burton ME; Sperling MR
Ther Drug Monit; 2002 Jun; 24(3):379-85. PubMed ID: 12021629
[TBL] [Abstract][Full Text] [Related]
2. Free phenytoin assessment in patients: measured versus calculated blood serum levels.
Tobler A; Hösli R; Mühlebach S; Huber A
Int J Clin Pharm; 2016 Apr; 38(2):303-9. PubMed ID: 26746902
[TBL] [Abstract][Full Text] [Related]
3. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
[TBL] [Abstract][Full Text] [Related]
5. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
[TBL] [Abstract][Full Text] [Related]
6. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
[TBL] [Abstract][Full Text] [Related]
7. Serum albumin-adjusted phenytoin levels: an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countries.
Tandon M; Pandhi P; Garg SK; Prabhakar SK
Int J Clin Pharmacol Ther; 2004 Oct; 42(10):550-5. PubMed ID: 15516024
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based implementation of free phenytoin therapeutic drug monitoring.
Burt M; Anderson DC; Kloss J; Apple FS
Clin Chem; 2000 Aug; 46(8 Pt 1):1132-5. PubMed ID: 10926893
[TBL] [Abstract][Full Text] [Related]
9. Plasma total phenytoin: a possibly misleading test in developing countries.
Fedler C; Stewart MJ
Ther Drug Monit; 1999 Apr; 21(2):155-60. PubMed ID: 10217333
[TBL] [Abstract][Full Text] [Related]
10. Alteration of phenytoin binding by glycosylation of albumin in IDDM.
Kemp SF; Kearns GL; Turley CP
Diabetes; 1987 Apr; 36(4):505-9. PubMed ID: 3817304
[TBL] [Abstract][Full Text] [Related]
11. Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies.
Perucca E
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():71-8. PubMed ID: 6423336
[TBL] [Abstract][Full Text] [Related]
12. Correlation of free phenytoin to serum albumin in cancer patients.
Umstead GS; Neumann KH
DICP; 1990 Oct; 24(10):923-6. PubMed ID: 2244404
[TBL] [Abstract][Full Text] [Related]
13. Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.
Krasowski MD; Penrod LE
BMC Med Inform Decis Mak; 2012 Feb; 12():7. PubMed ID: 22333264
[TBL] [Abstract][Full Text] [Related]
14. Prediction of free phenytoin levels based on [total phenytoin]/[albumin] ratios. Potential errors with hypoalbuminemia.
Dasgupta A; Dennen DA; Dean R; McLawhon RW
Am J Clin Pathol; 1991 Feb; 95(2):253-6. PubMed ID: 1992618
[TBL] [Abstract][Full Text] [Related]
15. Protein binding of phenytoin and lidocaine in pediatric patients with type I diabetes mellitus.
Kearns GL; Kemp SF; Turley CP; Nelson DL
Dev Pharmacol Ther; 1988; 11(1):14-23. PubMed ID: 3383718
[TBL] [Abstract][Full Text] [Related]
16. Utility of free level monitoring of antiepileptic drugs.
Levy RH; Schmidt D
Epilepsia; 1985; 26(3):199-205. PubMed ID: 3924585
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.
Buckley MS; Reeves BA; Barletta JF; Bikin DS
Ann Pharmacother; 2016 Apr; 50(4):276-81. PubMed ID: 26783351
[TBL] [Abstract][Full Text] [Related]
18. Free phenytoin monitoring in serum and saliva of epileptic patients in China.
Cai WM; Zhu GZ; Chen G
Ther Drug Monit; 1993 Feb; 15(1):31-4. PubMed ID: 8451777
[TBL] [Abstract][Full Text] [Related]
19. Age-related alteration of carbamazepine-serum protein binding in man.
Koyama H; Sugioka N; Uno A; Mori S; Nakajima K
J Pharm Pharmacol; 1999 Sep; 51(9):1009-14. PubMed ID: 10528982
[TBL] [Abstract][Full Text] [Related]
20. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
